INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 152 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $644,747 | +8.6% | 48,008 | 0.0% | 0.02% | +50.0% |
| Q4 2022 | $593,859 | -53.6% | 48,008 | -47.7% | 0.01% | -54.5% |
| Q3 2022 | $1,281,000 | +381.6% | 91,832 | +461.7% | 0.02% | +340.0% |
| Q1 2022 | $266,000 | 0.0% | 16,350 | 0.0% | 0.01% | -28.6% |
| Q4 2021 | $266,000 | -72.1% | 16,350 | -74.5% | 0.01% | -58.8% |
| Q3 2021 | $952,000 | -0.1% | 64,079 | +34.3% | 0.02% | 0.0% |
| Q2 2021 | $953,000 | – | 47,729 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 635,300 | $39,083,000 | 9.04% |
| Senvest Management, LLC | 1,152,032 | $70,873,000 | 5.40% |
| Melqart Asset Management (UK) Ltd | 298,200 | $18,345,000 | 2.20% |
| Elk Creek Partners, LLC | 348,454 | $21,437,000 | 1.25% |
| ALTRINSIC GLOBAL ADVISORS LLC | 375,223 | $23,084,000 | 0.93% |
| BB BIOTECH AG | 545,719 | $33,573,000 | 0.93% |
| Virtus ETF Advisers LLC | 14,681 | $903,000 | 0.78% |
| Opus Point Partners Management, LLC | 4,496 | $277,000 | 0.54% |
| Spark Investment Management LLC | 136,500 | $8,397,000 | 0.54% |
| Regal Investment Advisors LLC | 29,511 | $1,816,000 | 0.40% |